MicroPhage Receives $6,000,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=14390214-d27b-46a7-a4d7-73cb1084cd02&Preview=1 - Date
10/20/2011 - Company Name
MicroPhage - Mailing Address
2400 Trade Centre Avenue Longmont, CO 80503 - Company Description
MicroPhage’s mission is to be a worldwide leader in rapid bacterial diagnostics, in both bacterial identification and antibiotic susceptibility / resistance testing, through its bacteriophage-based amplification platform for immunoassay diagnostics. The company will develop, manufacture, and market these tests into the clinical market. - Website
http://www.microphage.com - Transaction Type
Debt, Venture Equity - Transaction Amount
$6,000,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
